REQUEST A DEMO
Total
USD $0.00
Search more companies

Slaviamed D.O.O. Beograd (Serbia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Slaviamed D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Slaviamed D.O.O. Beograd is a company in Serbia, with a head office in Belgrade. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on August 25, 1993. 76 (2024) employees currently work for Slaviamed D.O.O. Beograd. The latest financial highlights indicate a net sales revenue increase of 5.3% in 2024. A growth of 0.42% was recorded in its total assets. In 2024, Slaviamed D.O.O. Beograd’s net profit margin increased by 2.66%.

Headquarters
Bulevar Oslobodjenja 97
Belgrade; Belgrade;

Contact Details: Purchase the Slaviamed D.O.O. Beograd report to view the information.

Website: http://www.slaviamed.co.rs

Basic Information
Total Employees:
Purchase the Slaviamed D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Slaviamed D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Slaviamed D.O.O. Beograd report to view the information.
Incorporation Date:
August 25, 1993
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Astra Banka - U Stecaju
Company Performance
Financial values in the chart are available after Slaviamed D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
5.3%
Total Operating Revenue
9.72%
Operating Profit
39.48%
EBITDA
31.3%
Net Profit/Loss for the Period
45.8%
Total Assets
0.42%
Total Equity
14.54%
Operating Profit Margin
3.25%
Net Profit Margin
2.66%
Return on Equity (ROE)
4.79%
Debt / Equity
1.37%
Quick Ratio
0.57%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?